Physician profile
Pedro J Roque
NPI 1275617987
$4,338.27
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,791 · 2020: $729 · 2021: $336 · 2022: $528 · 2023: $784 · 2024: $51.30 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $863.33 | 2019-2025 | Farxiga |
| Novo Nordisk INC | $721.88 | 2019-2024 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $697.87 | 2019-2022 | |
| Amgen INC. | $586.64 | 2019-2025 | Evenity, Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $437.29 | 2019-2023 | Xarelto |
| Lilly USA, LLC | $325.04 | 2019-2023 | Jardiance |
| Apollo Endosurgery US INC | $149.21 | 2023 | Overstitch Endoscopic Suturing System |
| Merck Sharp & Dohme LLC | $107.23 | 2019-2020 | |
| Melinta Therapeutics, LLC | $85.47 | 2019 | |
| Smith+Nephew, INC. | $78.67 | 2019-2025 | Collagenase Santyl |
| Bayer Healthcare Pharmaceuticals INC. | $69.26 | 2023-2024 | |
| Insulet Corporation | $61.14 | 2021 | |
| Sanofi-Aventis U.S. LLC | $56.52 | 2019-2022 | |
| Amarin Pharma, INC. | $43.22 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $34.36 | 2019-2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $21.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Roque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.